Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Medical management of osteoporosis Kirk D; Fish SAAm J Manag Care 2004[Jul]; 10 (7 Pt 1): 445-55Osteoporosis is a cause of considerable morbidity and mortality in men and women. Medical intervention can reduce the progression of osteoporosis and decrease the fracture risk associated with low bone mineral density. In this article, we review the evidence for medical therapies for osteoporosis, including estrogen, calcitonin, bisphosphonates, selective estrogen receptor modulators, and the newest approved agent, recombinant human parathyroid hormone. We also discuss several controversial areas in osteoporosis treatment, including the management of men with osteoporosis, approach to monitoring the effects of osteoporosis therapy, and need for cost-effective strategies for osteoporosis treatment.|*Disease Management[MESH]|Calcium/administration & dosage[MESH]|Cost-Benefit Analysis[MESH]|Diphosphonates/therapeutic use[MESH]|Estrogen Receptor Modulators/therapeutic use[MESH]|Estrogens/therapeutic use[MESH]|Exercise[MESH]|Female[MESH]|Humans[MESH]|Male[MESH]|Osteoporosis/diagnosis/*drug therapy/etiology/therapy[MESH]|Parathyroid Hormone/therapeutic use[MESH]|Smoking Cessation[MESH]|United States[MESH]|Vitamin D/administration & dosage[MESH] |
